Mechanisms of action of retinal microglia in diabetic retinopathy (Review)
- Authors:
- Yuyang Bai
- Xinrong Wang
- Fan Qi
- Xiaoyang Zuo
- Gang Zou
-
Affiliations: Third Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750001, P.R. China, Department of Ophthalmology, Ningxia Eye Hospital, People's Hospital of Ningxia Hui Autonomous Region, Third Clinical School of Medicine, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750001, P.R. China - Published online on: September 22, 2025 https://doi.org/10.3892/ijmm.2025.5643
- Article Number: 202
-
Copyright : © Bai et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
World Health Organization (WHO): Global report on diabetes. WHO; Geneva: pp. 1–88. 2016 | |
|
Altmann C and Schmidt MHH: The role of microglia in diabetic retinopathy: Inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci. 19:1102018. View Article : Google Scholar : PubMed/NCBI | |
|
Obrosova IG and Kador PF: Aldose reductase/polyol inhibitors for diabetic retinopathy. Curr Pharm Biotechnol. 12:373–385. 2011. View Article : Google Scholar | |
|
Cheung N, Mitchell P and Wong TY: Diabetic retinopathy. Lancet. 376:124–136. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, et al: Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology. 128:1580–1591. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yang QH, Zhang Y, Zhang XM and Li XR: Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: A systematic review and meta-analysis. Int J Ophthalmol. 12:302–311. 2019.PubMed/NCBI | |
|
Cheyne CP, Burgess PI, Broadbent DM, García-Fiñana M, Stratton IM, Criddle T, Wang A, Alshukri A, Rahni MM, Vazquez-Arango P, et al: Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study. Diabet Med. 38:e145832021. View Article : Google Scholar : PubMed/NCBI | |
|
Das A, Stroud S, Mehta A and Rangasamy S: New treatments for diabetic retinopathy. Diabetes Obes Metab. 17:219–230. 2015. View Article : Google Scholar | |
|
Wei L, Sun X, Fan C, Li R, Zhou S and Yu H: The pathophysiological mechanisms underlying diabetic retinopathy. Front Cell Dev Biol. 10:9636152022. View Article : Google Scholar : PubMed/NCBI | |
|
Arroba AI, Alcalde-Estevez E, García-Ramírez M, Cazzoni D, de la Villa P, Sánchez-Fernández EM, Mellet CO, García Fernández JM, Hernández C, Simó R and Valverde ÁM: Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice. Biochim Biophys Acta. 1862:1663–1674. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kinuthia UM, Wolf A and Langmann T: Microglia and inflammatory responses in diabetic retinopathy. Front Immunol. 11:5640772020. View Article : Google Scholar : PubMed/NCBI | |
|
Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK and Ting JPY: TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci. 4:1116–1122. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Prinz M, Jung S and Priller J: Microglia biology: One century of evolving concepts. Cell. 179:292–311. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang S, Zhang J and Chen L: The cells involved in the pathological process of diabetic retinopathy. Biomed Pharmacother. 132:1108182020. View Article : Google Scholar : PubMed/NCBI | |
|
Van Furth R, Cohn ZA, Hirsch JG, Humphrey JH, Spector WG and Langevoort HL: The mononuclear phagocyte system: A new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ. 46:845–852. 1972.PubMed/NCBI | |
|
Rao B, Liu X, Xiao J, Wu X, He F, Yang Q, Zhao W, Lin X and Zhang J: Microglia heterogeneity during neuroinflammation and neurodegeneration in the mouse retina. Brain Struct Funct. 230:192024. View Article : Google Scholar : PubMed/NCBI | |
|
Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM and Langmann T: Retinal microglia: Just bystander or target for therapy? Prog Retin Eye Res. 45:30–57. 2015. View Article : Google Scholar | |
|
Usui Y: Elucidation of pathophysiology and novel treatment for diabetic macular edema derived from the concept of neurovascular unit. JMA J. 3:201–207. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hughes S, Yang H and Chan-Ling T: Vascularization of the human fetal retina: Roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci. 41:1217–1228. 2000. | |
|
Frost JL and Schafer DP: Microglia: Architects of the developing nervous system. Trends Cell Biol. 26:587–597. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rymo SF, Gerhardt H, Wolfhagen Sand F, Lang R, Uv A and Betsholtz C: A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS One. 6:e158462011. View Article : Google Scholar : PubMed/NCBI | |
|
Haupt F, Krishnasamy K, Napp LC, Augustynik M, Limbourg A, Gamrekelashvili J, Bauersachs J, Haller H and Limbourg FP: Retinal myeloid cells regulate tip cell selection and vascular branching morphogenesis via Notch ligand Delta-like 1. Sci Rep. 9:97982019. View Article : Google Scholar : PubMed/NCBI | |
|
Endo Y, Asanuma D, Namiki S, Sugihara K, Hirose K, Uemura A, Kubota Y and Miura T: Quantitative modeling of regular retinal microglia distribution. Sci Rep. 11:226712021. View Article : Google Scholar : PubMed/NCBI | |
|
Asare-Bediako B, Adu-Agyeiwaah Y, Abad A, Li Calzi S, Floyd JL, Prasad R, DuPont M, Asare-Bediako R, Bustelo XR and Grant MB: Hematopoietic cells influence vascular development in the retina. Cells. 11:32072022. View Article : Google Scholar : PubMed/NCBI | |
|
Perochon T, Krsnik Z, Massimo M, Ruchiy Y, Romero AL, Mohammadi E, Li X, Long KR, Parkkinen L, Blomgren K, et al: Unraveling microglial spatial organization in the developing human brain with DeepCellMap, a deep learning approach coupled with spatial statistics. Nat Commun. 16:15772025. View Article : Google Scholar : PubMed/NCBI | |
|
Li F, Jiang D and Samuel MA: Microglia in the developing retina. Neural Dev. 14:122019. View Article : Google Scholar | |
|
Zhou LY, Liu ZG, Sun YQ, Li YZ, Teng ZQ and Liu CM: Preserving blood-retinal barrier integrity: A path to retinal ganglion cell protection in glaucoma and traumatic optic neuropathy. Cell Regen. 14:132025. View Article : Google Scholar : PubMed/NCBI | |
|
Klaassen I, Van Noorden CJF and Schlingemann RO: Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res. 34:19–48. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Guymer RH, Bird AC and Hageman GS: Cytoarchitecture of choroidal capillary endothelial cells. Invest Ophthalmol Vis Sci. 45:1660–1666. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Hormel TT, Jia Y, Jian Y, Hwang TS, Bailey ST, Pennesi ME, Wilson DJ, Morrison JC and Huang D: Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography. Prog Retin Eye Res. 80:1008782021. View Article : Google Scholar : | |
|
Amoaku WM, Ghanchi F, Bailey C, Banerjee S, Banerjee S, Downey L, Gale R, Hamilton R, Khunti K, Posner E, et al: Diabetic retinopathy and diabetic macular oedema pathways and management: UK consensus working group. Eye (Lond). 34(Suppl 1): S1–S51. 2020. View Article : Google Scholar | |
|
Opdenakker G and Abu El-Asrar A: Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy. Cell Mol Life Sci. 76:3157–3166. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
O'Leary F and Campbell M: The blood-retina barrier in health and disease. FEBS J. 290:878–891. 2023. View Article : Google Scholar | |
|
Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA and Stevens B: Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 74:691–705. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu X, Hong J and Zhou X: Biological immune mechanism of retina. Front Biosci (Landmark Ed). 28:3632023. View Article : Google Scholar | |
|
Kumar A, Kumar A, Kumar J, Bai G, Jeewnani R, Dembra M, Kanwal K, Qadeer U, Khawar MH, Yaseen Khan I, et al: Comparative efficacy of anti-vascular endothelial growth factor (anti-VEGF) agents and corticosteroids in managing diabetic retinopathy-associated diabetic macular edema: A meta-analysis and comprehensive systematic review. Cureus. 16:e519102024.PubMed/NCBI | |
|
Lee WJ, Kang MH, Seong M and Cho HY: Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion. Br J Ophthalmol. 96:1426–1430. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Meng C, Gu C, He S, Su T, Lhamo T, Draga D and Qiu Q: Pyroptosis in the retinal neurovascular unit: New insights into diabetic retinopathy. Front Immunol. 12:7630922021. View Article : Google Scholar : PubMed/NCBI | |
|
Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R and Verges R: Diabetic macular edema pathophysiology: Vasogenic versus inflammatory. J Diabetes Res. 2016:21562732016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Zhao L, Wang X, Ma W, Lazere A, Qian HH, Zhang J, Abu-Asab M, Fariss RN, Roger JE and Wong WT: Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation. Sci Adv. 4:eaap84922018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao L, Zabel MK, Wang X, Ma W, Shah P, Fariss RN, Qian H, Parkhurst CN, Gan WB and Wong WT: Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration. EMBO Mol Med. 7:1179–1197. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, He W and Zhang J: A richer and more diverse future for microglia phenotypes. Heliyon. 9:e147132023. View Article : Google Scholar : PubMed/NCBI | |
|
Fouda AY, Xu Z, Suwanpradid J, Rojas M, Shosha E, Lemtalsi T, Patel C, Xing J, Zaidi SA, Zhi W, et al: Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair. Cell Death Dis. 13:7452022. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Yu ZW, Li HY, Yuan Y, Gao XY and Kuang HY: Retinal microglia polarization in diabetic retinopathy. Vis Neurosci. 38:E0062021. View Article : Google Scholar : PubMed/NCBI | |
|
Ikeda T, Nakamura K, Kida T and Oku H: Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 260:387–403. 2022. View Article : Google Scholar : | |
|
Ibrahim AS, El-Shishtawy MM, Peña A Jr and Liou GI: Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis. 16:2033–2042. 2010.PubMed/NCBI | |
|
Cukras CA, Petrou P, Chew EY, Meyerle CB and Wong WT: Oral minocycline for the treatment of diabetic macular edema (DME): Results of a phase I/II clinical study. Invest Ophthalmol Vis Sci. 53:3865–3874. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Madeira MH, Boia R, Santos PF, Ambrósio AF and Santiago AR: Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm. 2015:6730902015. View Article : Google Scholar : PubMed/NCBI | |
|
Grigsby JG, Cardona SM, Pouw CE, Muniz A, Mendiola AS, Tsin ATC, Allen DM and Cardona AE: The role of microglia in diabetic retinopathy. J Ophthalmol. 2014:7057832014. View Article : Google Scholar : PubMed/NCBI | |
|
Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, Amit I, Audinat E, Bechmann I, Bennett M, et al: Microglia states and nomenclature: A field at its crossroads. Neuron. 110:3458–3483. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Sun N, Victor MB, Park YP, Xiong X, Scannail AN, Leary N, Prosper S, Viswanathan S, Luna X, Boix CA, et al: Human microglial state dynamics in Alzheimer's disease progression. Cell. 186:4386–4403.e29. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
He J, Fu Y, Ge L, Dai J, Fang Y, Li Y, Gu X, Tao Z, Zou T, Li M, et al: Disease-associated microglial activation prevents photoreceptor degeneration by suppressing the accumulation of cell debris and neutrophils in degenerating rat retinas. Theranostics. 12:2687–2706. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Shemer A, Grozovski J, Tay TL, Tao J, Volaski A, Süß P, Ardura-Fabregat A, Gross-Vered M, Kim JS, David E, et al: Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge. Nat Commun. 9:52062018. View Article : Google Scholar : PubMed/NCBI | |
|
Buttgereit A, Lelios I, Yu X, Vrohlings M, Krakoski NR, Gautier EL, Nishinakamura R, Becher B and Greter M: Sall1 is a transcriptional regulator defining microglia identity and function. Nat Immunol. 17:1397–1406. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jurga AM, Paleczna M and Kuter KZ: Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci. 14:1982020. View Article : Google Scholar : PubMed/NCBI | |
|
Wolf J, Boneva S, Rosmus DD, Agostini H, Schlunck G, Wieghofer P, Schlecht A and Lange C: In-depth molecular profiling specifies human retinal microglia identity. Front Immunol. 13:8631582022. View Article : Google Scholar : PubMed/NCBI | |
|
Masuda T, Amann L, Sankowski R, Staszewski O, Lenz M, D'Errico P, Snaidero N, Costa Jordão MJ, Böttcher C, Kierdorf K, et al: Novel Hexb-based tools for studying microglia in the CNS. Nat Immunol. 21:802–815. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kenkhuis B, Somarakis A, Kleindouwel LRT, Van Roon-Mom WMC, Höllt T and Van Der Weerd L: Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease. Neurobiol Dis. 167:1056842022. View Article : Google Scholar : PubMed/NCBI | |
|
Qin Z, He S, Yang C, Yung JSY, Chen C, Leung CKS, Liu K and Qu JY: Adaptive optics two-photon microscopy enables near-diffraction-limited and functional retinal imaging in vivo. Light Sci Appl. 9:792020. View Article : Google Scholar : PubMed/NCBI | |
|
Wu MY, Yiang GT, Lai TT and Li CJ: The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy. Oxidative Med Cell Longev. 2018:34201872018. View Article : Google Scholar | |
|
Lv K, Ying H, Hu G, Hu J, Jian Q and Zhang F: Integrated multi-omics reveals the activated retinal microglia with intracellular metabolic reprogramming contributes to inflammation in STZ-induced early diabetic retinopathy. Front Immunol. 13:9427682022. View Article : Google Scholar : PubMed/NCBI | |
|
Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J and Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA. 97:12222–12226. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Du X, Matsumura T, Edelstein D, Rossetti L, Zsengellér Z, Szabó C and Brownlee M: Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Investig. 112:1049–1057. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kowluru RA: Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sci. 76:1051–1060. 2005. View Article : Google Scholar | |
|
Glomb MA and Monnier VM: Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the maillard reaction. J Biol Chem. 270:10017–10026. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Funatsu H and Yamashita H: Pathogenesis of diabetic retinopathy and the renin-angiotensin system. Ophthalmic Physiol Opt. 23:495–501. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Cai Y, Li W, Tu H, Chen N, Zhong Z, Yan P and Dong J: Curcumolide reduces diabetic retinal vascular leukostasis and leakage partly via inhibition of the p38MAPK/NF-κB signaling. Bioorg Med Chem Lett. 27:1835–1839. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Stitt AW: The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol. 75:95–108. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yamagishi SI and Matsui T: Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy. Curr Pharm Biotechnol. 12:362–368. 2011. View Article : Google Scholar | |
|
Song J and Lee JE: ASK1 modulates the expression of microRNA Let7A in microglia under high glucose in vitro condition. Front Cell Neurosci. 9:1982015. View Article : Google Scholar : PubMed/NCBI | |
|
Du A, Xie Y, Ouyang H, Lu B, Jia W, Xu H and Ji L: Si-miao-yong-an decoction for diabetic retinopathy: A combined network pharmacological and in vivo approach. Front Pharmacol. 12:7631632021. View Article : Google Scholar : PubMed/NCBI | |
|
Vargas-Soria M, García-Alloza M and Corraliza-Gómez M: Effects of diabetes on microglial physiology: A systematic review of in vitro, preclinical and clinical studies. J Neuroinflammation. 20:572023. View Article : Google Scholar : PubMed/NCBI | |
|
Quiriconi P, Hristov V, Aburaya M, Greferath U, Jobling AI and Fletcher EL: The role of microglia in the development of diabetic retinopathy. NPJ Metab Health Dis. 2:72024. View Article : Google Scholar : PubMed/NCBI | |
|
Cai L, Xia M and Zhang F: Redox regulation of immunometabolism in microglia underpinning diabetic retinopathy. Antioxidants (Basel). 13:4232024. View Article : Google Scholar : PubMed/NCBI | |
|
Yamaguchi M, Nakao S, Arima M, Little K, Singh A, Wada I, Kaizu Y, Zandi S, Garweg JG, Matoba T, et al: Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation. Diabetologia. 67:2329–2345. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Liu X, Wei W, Yang J, Li Q, Chu S, Liu P, Zhang J and He W: Regulation of oxygen-glucose deprivation/reperfusion-induced inflammatory responses and M1-M2 phenotype switch of BV2 microglia by lobetyolin. Metab Brain Dis. 38:2627–2644. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Nian S, Lo ACY, Mi Y, Ren K and Yang D: Neurovascular unit in diabetic retinopathy: Pathophysiological roles and potential therapeutical targets. Eye Vis (Lond Engl). 8:152021. View Article : Google Scholar | |
|
Inada M, Xu H, Takeuchi M, Ito M and Chen M: Microglia increase tight-junction permeability in coordination with Müller cells under hypoxic condition in an in vitro model of inner blood-retinal barrier. Exp Eye Res. 205:1084902021. View Article : Google Scholar | |
|
Fang M, Wan W, Li Q, Wan W, Long Y, Liu H and Yang X: Asiatic acid attenuates diabetic retinopathy through TLR4/MyD88/NF-κB p65 mediated modulation of microglia polarization. Life Sci. 277:1195672021. View Article : Google Scholar | |
|
Mehrabadi AR, Korolainen MA, Odero G, Miller DW and Kauppinen TM: Poly(ADP-ribose) polymerase-1 regulates microglia mediated decrease of endothelial tight junction integrity. Neurochem Int. 108:266–271. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Usui-Ouchi A, Usui Y, Kurihara T, Aguilar E, Dorrell MI, Ideguchi Y, Sakimoto S, Bravo S and Friedlander M: Retinal microglia are critical for subretinal neovascular formation. JCI Insight. 5:e1373172020. View Article : Google Scholar : PubMed/NCBI | |
|
Xie H, Zhang C, Liu D, Yang Q, Tang L, Wang T, Tian H, Lu L, Xu JY, Gao F, et al: Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy. Diabetologia. 64:211–225. 2021. View Article : Google Scholar | |
|
Zhang T, Ouyang H, Mei X, Lu B, Yu Z, Chen K, Wang Z and Ji L: Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-κB signaling pathway. FASEB J. 33:11776–11790. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Behnke V, Wolf A and Langmann T: The role of lymphocytes and phagocytes in age-related macular degeneration (AMD). Cell Mol Life Sci. 77:781–788. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ogura S, Baldeosingh R, Bhutto IA, Kambhampati SP, McLeod DS, Edwards MM, Rais R, Schubert W and Lutty GA: A role for mast cells in geographic atrophy. FASEB J. 34:10117–10131. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lueck K, Busch M, Moss SE, Greenwood J, Kasper M, Lommatzsch A, Pauleikhoff D and Wasmuth S: Complement stimulates retinal pigment epithelial cells to undergo pro-inflammatory changes. Ophthalmic Res. 54:195–203. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fu X, Feng S, Qin H, Yan L, Zheng C and Yao K: Microglia: The breakthrough to treat neovascularization and repair blood-retinal barrier in retinopathy. Front Mol Neurosci. 16:11002542023. View Article : Google Scholar : PubMed/NCBI | |
|
Ding X, Gu R, Zhang M, Ren H, Shu Q, Xu G and Wu H: Microglia enhanced the angiogenesis, migration and proliferation of co-cultured RMECs. BMC Ophthalmol. 18:2492018. View Article : Google Scholar : PubMed/NCBI | |
|
Hu A, Schmidt MHH and Heinig N: Microglia in retinal angiogenesis and diabetic retinopathy. Angiogenesis. 27:311–331. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Tang L, Xu GT and Zhang JF: Inflammation in diabetic retinopathy: Possible roles in pathogenesis and potential implications for therapy. Neural Regen Res. 18:976–982. 2023. View Article : Google Scholar : | |
|
Ogura S, Kurata K, Hattori Y, Takase H, Ishiguro-Oonuma T, Hwang Y, Ahn S, Park I, Ikeda W, Kusuhara S, et al: Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown. JCI Insight. 2:e909052017. View Article : Google Scholar : PubMed/NCBI | |
|
He C, Liu Y, Huang Z, Yang Z, Zhou T, Liu S, Hao Z, Wang J, Feng Q, Liu Y, et al: A specific RIP3+ subpopulation of microglia promotes retinopathy through a hypoxia-triggered necroptotic mechanism. Proc Natl Acad Sci USA. 118:e20232901182021. View Article : Google Scholar | |
|
Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D, et al: Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 13:868–873. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Yin J, Xu WQ, Ye MX, Zhang Y, Wang HY, Zhang J, Li Y and Wang YS: Up-regulated basigin-2 in microglia induced by hypoxia promotes retinal angiogenesis. J Cell Mol Med. 21:3467–3480. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao C, Liu Y, Meng J, Wang X, Liu X, Li W, Zhou Q, Xiang J, Li N and Hou S: LGALS3BP in microglia promotes retinal angiogenesis through PI3K/AKT pathway during hypoxia. Invest Ophthalmol Vis Sci. 63:252022. View Article : Google Scholar : PubMed/NCBI | |
|
Murinello S, Usui Y, Sakimoto S, Kitano M, Aguilar E, Friedlander HM, Schricker A, Wittgrove C, Wakabayashi Y, Dorrell MI, et al: miR-30a-5p inhibition promotes interaction of Fas+ endothelial cells and FasL+ microglia to decrease pathological neovascularization and promote physiological angiogenesis. Glia. 67:332–344. 2019. View Article : Google Scholar | |
|
Luo Q, Jiang Z, Jiang J, Wan L, Li Y, Huang Y, Qiu J, Yu K and Zhuang J: Tsp-1+ microglia attenuate retinal neovascularization by maintaining the expression of Smad3 in endothelial cells through exosomes with decreased miR-27a-5p. Theranostics. 13:3689–3706. 2023. View Article : Google Scholar : | |
|
Hu Y, Wei T, Gao S and Cheng Q: Anti-angiogenic and anti-inflammatory effects of CD200-CD200R1 axis in oxygen-induced retinopathy mice model. Inflamm Res. 68:945–955. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dejda A, Mawambo G, Daudelin JF, Miloudi K, Akla N, Patel C, Andriessen EMMA, Labrecque N, Sennlaub F and Sapieha P: Neuropilin-1-expressing microglia are associated with nascent retinal vasculature yet dispensable for developmental angiogenesis. Invest Ophthalmol Vis Sci. 57:1530–1536. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Dejda A, Mawambo G, Cerani A, Miloudi K, Shao Z, Daudelin JF, Boulet S, Oubaha M, Beaudoin F, Akla N, et al: Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk. J Clin Investig. 124:4807–4822. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bai Q, Wang X, Yan H, Wen L, Zhou Z, Ye Y, Jing Y, Niu Y, Wang L, Zhang Z, et al: Microglia-derived Spp1 promotes pathological retinal neovascularization via activating endothelial Kit/Akt/mTOR signaling. J Pers Med. 13:1462023. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou ZY, Chang TF, Lin ZB, Jing YT, Wen LS, Niu YL, Bai Q, Guo CM, Sun JX, Wang YS and Dou GR: Microglial Galectin3 enhances endothelial metabolism and promotes pathological angiogenesis via notch inhibition by competitively binding to Jag1. Cell Death Dis. 14:3802023. View Article : Google Scholar : PubMed/NCBI | |
|
Li L, Sun B, Harris OA and Luo J: TGF-β signaling in microglia: A key regulator of development, homeostasis and reactivity. Biomedicines. 12:24682024. View Article : Google Scholar | |
|
Wiens KR, Wasti N, Ulloa OO and Klegeris A: Diversity of microglia-derived molecules with neurotrophic properties that support neurons in the central nervous system and other tissues. Molecules. 29:55252024. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W, Tong B, Xiong J, Zhu Y, Lu H, Xu H, Yang X, Wang F, Yu P and Hu Y: Identification of macrophage polarisation and mitochondria-related biomarkers in diabetic retinopathy. J Transl Med. 23:232025. View Article : Google Scholar : PubMed/NCBI | |
|
Amankwa CE, Acha LG, Dibas A, Chavala SH, Roth S, Mathew B and Acharya S: Neuroprotective and anti-inflammatory activities of hybrid small-molecule SA-10 in ischemia/reperfusion-induced retinal neuronal injury models. Cells. 13:3962024. View Article : Google Scholar : PubMed/NCBI | |
|
Paisley CE and Kay JN: Seeing stars: Development and function of retinal astrocytes. Dev Biol. 478:144–154. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Chan-Ling T: Development of the retinal vasculature. Encyclopedia of the eye. D'Amore P: Academic Press; Cambridge: pp. 22–33. 2010, View Article : Google Scholar | |
|
Gnanaguru G, Tabor SJ, Bonilla GM, Sadreyev R, Yuda K, Köhl J and Connor KM: Microglia refine developing retinal astrocytic and vascular networks through the complement C3/C3aR axis. Development. 150:dev2010472023. View Article : Google Scholar : PubMed/NCBI | |
|
Checchin D, Sennlaub F, Levavasseur E, Leduc M and Chemtob S: Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci. 47:3595–3602. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Wang M, Ma W, Zhao L, Fariss RN and Wong WT: Adaptive Müller cell responses to microglial activation mediate neuroprotection and coordinate inflammation in the retina. J Neuroinflammation. 8:1732011. View Article : Google Scholar | |
|
Tewari M, Michalski S and Egan TM: Modulation of microglial function by ATP-gated P2X7 receptors: Studies in rat, mice and human. Cells. 13:1612024. View Article : Google Scholar : PubMed/NCBI | |
|
Kong H, Zhao H, Chen T, Song Y and Cui Y: Targeted P2X7/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy. Cell Death Dis. 13:3362022. View Article : Google Scholar : PubMed/NCBI | |
|
Antonetti DA, Silva PS and Stitt AW: Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 17:195–206. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Ye J and Liu W: GPER-mediated inhibition of astrocyte activation mitigates retinal neovascularization in oxygen-induced retinopathy mice. J Army Med Univ. 46:1369–1377. 2024. | |
|
Kaur C, Foulds W and Ling E: Blood-retinal barrier in hypoxic ischaemic conditions: Basic concepts, clinical features and management. Prog Retin Eye Res. 27:622–647. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Puebla M, Tapia PJ and Espinoza H: Key role of astrocytes in postnatal brain and retinal angiogenesis. Int J Mol Sci. 23:26462022. View Article : Google Scholar : PubMed/NCBI | |
|
Navarro HI, Daly AE, Rodriguez B, Wu S, Ngo KA, Fraser A, Schiffman A, Liu Y, Smale ST, Chia JJ and Hoffmann A: NF-κB RelB suppresses the inflammatory gene expression programs of dendritic cells by competing with RelA for binding to target gene promoters. Cell Discov. 11:132025. View Article : Google Scholar | |
|
Acioglu C and Elkabes S: Innate immune sensors and regulators at the blood brain barrier: Focus on toll-like receptors and inflammasomes as mediators of neuro-immune crosstalk and inflammation. J Neuroinflammation. 22:392025. View Article : Google Scholar : PubMed/NCBI | |
|
Song Y, Dou H, Gong W, Liu X, Yu Z, Li E, Tan R and Hou Y: Bis-N-norgliovictin, a small-molecule compound from marine fungus, inhibits LPS-induced inflammation in macrophages and improves survival in sepsis. Eur J Pharmacol. 705:49–60. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Abcouwer SF: Neural inflammation and the microglial response in diabetic retinopathy. J Ocul Biol Dis Infor. 4:25–33. 2012. View Article : Google Scholar : | |
|
Sun H, Ma X, Ma H, Li S, Xia Y, Yao L, Wang Y, Pang X, Zhong J, Yao G, et al: High glucose levels accelerate atherosclerosis via NLRP3-IL/MAPK/NF-κB-related inflammation pathways. Biochem Biophys Res Commun. 704:1497022024. View Article : Google Scholar | |
|
He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW and Li B: Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 6:4252021. View Article : Google Scholar : PubMed/NCBI | |
|
Chidiac R, Zhang Y, Tessier S, Faubert D, Delisle C and Gratton JP: Comparative phosphoproteomics analysis of VEGF and angiopoietin-1 signaling reveals ZO-1 as a critical regulator of endothelial cell proliferation. Mol Cell Proteom. 15:1511–1525. 2016. View Article : Google Scholar | |
|
Greene C, Hanley N and Campbell M: Claudin-5: Gatekeeper of neurological function. Fluids Barriers CNS. 16:32019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao H, Lv Y, Xu J, Song X, Wang Q, Zhai X, Ma X, Qiu J, Cui L and Sun Y: The activation of microglia by the complement system in neurodegenerative diseases. Ageing Res Rev. 104:1026362025. View Article : Google Scholar | |
|
Ricklin D, Hajishengallis G, Yang K and Lambris JD: Complement: A key system for immune surveillance and homeostasis. Nat Immunol. 11:785–797. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ayyubova G and Madhu LN: Microglial NLRP3 inflammasomes in Alzheimer's disease pathogenesis: From interaction with autophagy/mitophagy to therapeutics. Mol Neurobiol. 62:7124–7143. 2025. View Article : Google Scholar : PubMed/NCBI | |
|
Yanai R, Thanos A and Connor KM: Complement involvement in neovascular ocular diseases. Adv Exp Med Biol. 946:161–183. 2012. View Article : Google Scholar | |
|
Padmakumar L, Menon RN, Gopala S and Vilanilam GC: MTH1 in the disorders of the central nervous system: Scope beyond brain tumors and challenges. Acta Neurol Belg. Feb 17–2025.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI | |
|
Chung J, Jernigan J, Menees KB and Lee JK: RGS10 mitigates high glucose-induced microglial inflammation via the reactive oxidative stress pathway and enhances synuclein clearance in microglia. Front Cell Neurosci. 18:13742982024. View Article : Google Scholar : PubMed/NCBI | |
|
Homme RP, Sandhu HS, George AK, Tyagi SC and Singh M: Sustained inhibition of NF-κB activity mitigates retinal vasculopathy in diabetes. Am J Pathol. 191:947–964. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Park SS: Retinal glia and NF-κB in diabetic retinopathy pathogenesis. Ann Transl Med. 11:3072023. View Article : Google Scholar | |
|
Chen W, Wu Z, Cheng Z, Zhang Y, Luo Q and Yin M: HO-1 represses NF-κB signaling pathway to mediate microglia polarization and phagocytosis in intracerebral hemorrhage. Neuroscience. 566:17–27. 2025. View Article : Google Scholar | |
|
Gonzalez-Cortes JH, Martinez-Pacheco VA, Gonzalez-Cantu JE, Bilgic A, de Ribot FM, Sudhalkar A, Mohamed-Hamsho J, Kodjikian L and Mathis T: Current treatments and innovations in diabetic retinopathy and diabetic macular edema. Pharmaceutics. 15:1222022. View Article : Google Scholar | |
|
Mounirou BAM, Adam ND, Yakoura AKH, Aminou MSM, Liu YT and Tan LY: Diabetic retinopathy: An overview of treatments. Indian J Endocrinol Metab. 26:111–118. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Arrigo A, Aragona E and Bandello F: VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy. Ann Med. 54:1089–1111. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W, Geng J and Sang A: Effectiveness of panretinal photocoagulation plus intravitreal anti-VEGF treatment against PRP alone for diabetic retinopathy: A systematic review with meta-analysis. Front Endocrinol (Lausanne). 13:8076872022. View Article : Google Scholar : PubMed/NCBI | |
|
Shukla UV and Tripathy K: Diabetic retinopathy. StatPearls [Internet]. StatPearls Publishing; Treasure Island, FL: 2025 | |
|
Vergmann AS, Nguyen TT, Lee Torp T, Kawasaki R, Wong TY, Peto T and Grauslund J: Efficacy and side effects of individualized panretinal photocoagulation. Ophthalmol Retina. 4:642–644. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu W, Cheng W, Cui X and Xu G: Therapeutic effect against retinal neovascularization in a mouse model of oxygen-induced retinopathy: Bone marrow-derived mesenchymal stem cells versus Conbercept. BMC Ophthalmol. 20:72020. View Article : Google Scholar : PubMed/NCBI | |
|
Martinez-Alejo JM, Baiza-Duran LM and Quintana-Hau JDD: Novel therapies for proliferative retinopathies. Ther Adv Chronic Dis. 13:204062232211403952022. View Article : Google Scholar : PubMed/NCBI | |
|
Xu W, Hu Z, Lv Y, Dou G, Zhang Z, Wang H and Wang Y: Microglial density determines the appearance of pathological neovascular tufts in oxygen-induced retinopathy. Cell Tissue Res. 374:25–38. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Qin S, Zhang C, Qin H, Xie H, Luo D, Qiu Q, Liu K and Zhang J, Xu G and Zhang J: Hyperreflective foci and subretinal fluid are potential imaging biomarkers to evaluate anti-VEGF effect in diabetic macular edema. Front Physiol. 12:7914422021. View Article : Google Scholar | |
|
Rojo Arias JE, Englmaier VE and Jászai J: VEGF-trap modulates retinal inflammation in the murine oxygen-induced retinopathy (OIR) model. Biomedicines. 10:2012022. View Article : Google Scholar : PubMed/NCBI | |
|
Palmhof M, Lohmann S, Schulte D, Stute G, Wagner N, Dick HB and Joachim SC: Fewer functional deficits and reduced cell death after ranibizumab treatment in a retinal ischemia model. Int J Mol Sci. 19:16362018. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Lu X, Hu Y, Yang B, Tsui CK, Yu S, Lu L and Liang X: Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1α-VEGF pathway in oxygen-induced retinopathy mice. J Pineal Res. 64:e124732018. View Article : Google Scholar | |
|
Wang JH, Lin FL, Chen J, Zhu L, Chuang YF, Tu L, Ma C, Ling D, Hewitt AW, Tseng CL, et al: TAK1 blockade as a therapy for retinal neovascularization. Pharmacol Res. 187:1066172023. View Article : Google Scholar | |
|
Church KA, Rodriguez D, Mendiola AS, Vanegas D, Gutierrez IL, Tamayo I, Amadu A, Velazquez P, Cardona SM, Gyoneva S, et al: Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1I249/M280-expressing retina. Front Immunol. 14:11307352023. View Article : Google Scholar | |
|
Church KA, Rodriguez D, Vanegas D, Gutierrez IL, Cardona SM, Madrigal JLM, Kaur T and Cardona AE: Models of microglia depletion and replenishment elicit protective effects to alleviate vascular and neuronal damage in the diabetic murine retina. J Neuroinflammation. 19:3002022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao F, Gao X, Ge X, Cui J and Liu X: Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy. Bioengineered. 12:9266–9278. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yang B, Xu Y, Yu S, Huang Y, Lu L and Liang X: Anti-angiogenic and anti-inflammatory effect of Magnolol in the oxygen-induced retinopathy model. Inflamm Res. 65:81–93. 2016. View Article : Google Scholar | |
|
Tang X, Cui K, Lu X, Wu P, Yu S, Yang B, Xu Y and Liang X: A novel hypoxia-inducible factor 1α inhibitor KC7F2 attenuates oxygen-induced retinal neovascularization. Invest Ophthalmol Vis Sci. 63:132022. View Article : Google Scholar | |
|
Song GJ and Suk K: Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases. Front Aging Neurosci. 9:1392017. View Article : Google Scholar : PubMed/NCBI | |
|
Sun X, Ma L, Li X, Wang J, Li Y and Huang Z: Ferulic acid alleviates retinal neovascularization by modulating microglia/macrophage polarization through the ROS/NF-κB axis. Front Immunol. 13:9767292022. View Article : Google Scholar | |
|
Wang Y, Chang T, Wu T, Xu W, Dou G, Wang Y and Guo C: M2 macrophages promote vasculogenesis during retinal neovascularization by regulating bone marrow-derived cells via SDF-1/VEGF. Cell Tissue Res. 380:469–486. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Yoshida S, Nakao S, Yoshimura T, Kobayashi Y, Nakama T, Kubo Y, Miyawaki K, Yamaguchi M, Ishikawa K, et al: M2 macrophages enhance pathological neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 56:4767–4777. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Caldwell RW, Rodriguez PC, Toque HA, Narayanan SP and Caldwell RB: Arginase: A multifaceted enzyme important in health and disease. Physiol Rev. 98:641–665. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Monticelli LA, Buck MD, Flamar AL, Saenz SA, Tait Wojno ED, Yudanin NA, Osborne LC, Hepworth MR, Tran SV, Rodewald HR, et al: Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat Immunol. 17:656–665. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chen T, Huang X, Zhao YX, Zhou ZW and Zhou WS: NEAT1 inhibits the angiogenic activity of cerebral arterial endothelial cells by inducing the M1 polarization of microglia through the AMPK signaling pathway. Cell Mol Biol Lett. 29:622024. View Article : Google Scholar : PubMed/NCBI | |
|
Niu G and Chen X: Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets. 11:1000–1017. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Cho H, Kambhampati SP, Lai MJ, Zhou L, Lee G, Xie Y, Hui Q, Kannan RM and Duh EJ: Dendrimer-triamcinolone acetonide reduces neuroinflammation, pathological angiogenesis, and neuroretinal dysfunction in ischemic retinopathy. Adv Ther (Weinh). 4:20001812021. View Article : Google Scholar : PubMed/NCBI | |
|
Fan W, Huang W, Chen J, Li N, Mao L and Hou S: Retinal microglia: Functions and diseases. Immunology. 166:268–286. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Zhang J, Chen J, Tang L, Ke M, Xue Y, He Y, Gong Y and Li Z: ω-3PUFAs inhibit hypoxia-induced retinal neovascularization via regulating microglial pyroptosis through METTL14-mediated m6A modification of IFNB1 mRNA. Appl Biochem Biotechnol. 196:5936–5952. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Mei X, Zhou L, Zhang T, Lu B, Sheng Y and Ji L: Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis. Vasc Pharmacol. 101:29–37. 2018. View Article : Google Scholar | |
|
Yu Z, Zhang T, Gong C, Sheng Y, Lu B, Zhou L, Ji L and Wang Z: Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway. Sci Rep. 6:343062016. View Article : Google Scholar | |
|
Zhao K, Jiang Y, Zhang J, Shi J, Zheng P, Yang C and Chen Y: Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway. Cell Cycle. 21:2091–2108. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Guo L, Choi S, Bikkannavar P and Cordeiro MF: Microglia: Key players in retinal ageing and neurodegeneration. Front Cell Neurosci. 16:8047822022. View Article : Google Scholar : PubMed/NCBI | |
|
Shao F, Wang X, Wu H, Wu Q and Zhang J: Microglia and neuroinflammation: Crucial pathological mechanisms in traumatic brain injury-induced neurodegeneration. Front Aging Neurosci. 14:8250862022. View Article : Google Scholar : PubMed/NCBI | |
|
Gao C, Jiang J, Tan Y and Chen S: Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets. Signal Transduct Target Ther. 8:3592023. View Article : Google Scholar : PubMed/NCBI | |
|
Yang I, Han SJ, Kaur G, Crane C and Parsa AT: The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci. 17:6–10. 2010. View Article : Google Scholar | |
|
Masuda T, Sankowski R, Staszewski O and Prinz M: Microglia heterogeneity in the single-cell era. Cell Rep. 30:1271–1281. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jiao W, Ji J, Li F, Guo J, Zheng Y, Li S and Xu W: Activation of the Notch-Nox4-reactive oxygen species signaling pathway induces cell death in high glucose-treated human retinal endothelial cells. Mol Med Rep. 19:667–677. 2019. | |
|
Seo H, Park SJ and Song M: Diabetic retinopathy (DR): Mechanisms, current therapies, and emerging strategies. Cells. 14:3762025. View Article : Google Scholar : PubMed/NCBI | |
|
Radwan SES, El-Kamel A, Zaki EI, Burgalassi S, Zucchetti E and El-Moslemany RM: Hyaluronic-coated albumin nanoparticles for the non-invasive delivery of apatinib in diabetic retinopathy. Int J Nanomedicine. 16:4481–4494. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Yang H, Zheng J, Tong A, Mu S, Wang D, Zhao M and Li J: Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications. Theranostics. 15:3551–3570. 2025. View Article : Google Scholar : PubMed/NCBI |
